Cardiovascular

Acute ischemic stroke trends in Slovenia, 2015-2022: declining admissions, rising reperfusion, uneven gains.

TL;DR

Crude ischaemic stroke admissions declined modestly in Slovenia from 2015–2022 while reperfusion and prevention improved, but the magnitude and pattern of improvement differed by care domain and patient subgroup, supporting continued monitoring and the development of a national stroke registry.

Key Findings

Ischaemic stroke admissions peaked in 2017 and crude admission rates declined modestly over the study period.

  • 16,839 unique index patients were included over the 2015–2022 period.
  • Admissions peaked in 2017 at 2,169 admissions.
  • Crude rates decreased from 105 to 99 per 100,000 residents by 2022.
  • The median patient age was 74 years and 54% were male.

Intravenous thrombolysis (IVT) rates more than doubled over the study period.

  • IVT rates increased from 6.2% to 15% between 2015 and 2022.
  • This represents a more than two-fold relative increase in IVT utilization.
  • IVT was associated with lower five-year mortality in time-to-death analyses.
  • IVT rates were similar between men and women.

Mechanical thrombectomy (MT) utilization increased substantially over the study period.

  • MT rates increased from 5.4% to 9.5% between 2015 and 2022.
  • MT rates were similar between men and women.
  • MT was captured as part of linked national administrative databases in the absence of a dedicated stroke registry.

Carotid endarterectomy (CEA) rates increased and showed sex-based differences in utilization.

  • CEA rates increased from 9.1% to 14% over the study period.
  • Men underwent more CEA and carotid artery angioplasty with stenting (CAS) than women.
  • CAS utilization also differed by sex, with men receiving this procedure more frequently.

Five-year mortality was higher with increasing age and comorbidity and lower among patients receiving IVT and several secondary-prevention therapies.

  • Time-to-death analyses were conducted with a maximum follow-up of 5 years.
  • Higher age was independently associated with higher five-year mortality.
  • Greater comorbidity burden was associated with higher five-year mortality.
  • Receipt of IVT was associated with lower five-year mortality.
  • Several secondary-prevention therapies at discharge were also associated with lower five-year mortality.

Discharge secondary-prevention prescription rates improved over the study period.

  • Improvement in discharge prevention therapy was observed across the 2015–2022 period.
  • Secondary-prevention prescriptions at discharge were associated with lower five-year mortality in time-to-death analyses.
  • Specific drug classes were captured via linked national administrative databases.

Length of hospital stay decreased over the study period.

  • Declining length of stay was observed alongside increasing reperfusion rates from 2015 to 2022.
  • This was identified using linked national administrative databases.
  • The analysis was nationwide, covering all adult hospital admissions in Slovenia.

Women with ischaemic stroke were older than men, and care pathway differences existed by stroke aetiology and sex.

  • Women were older than men at the time of ischaemic stroke admission.
  • Men underwent more CAS and CEA procedures than women.
  • IVT and MT rates were similar between sexes.
  • Care pathways differed by stroke aetiology across the study population.

The study used linked national administrative databases in the absence of a dedicated stroke registry to conduct a nationwide longitudinal analysis.

  • Data were drawn from linked national administrative datasets covering 2015–2022.
  • The study captured crude index-admission rates, acute procedures, discharge prescriptions, and time-to-death outcomes.
  • Slovenia does not have a dedicated stroke registry, and this approach was used as an alternative.
  • The authors conclude that findings support the development of a national stroke registry.

What This Means

This research suggests that in Slovenia between 2015 and 2022, the number of people admitted to hospital with an acute ischaemic stroke (caused by a blood clot blocking a blood vessel in the brain) declined slightly, going from about 105 to 99 admissions per 100,000 residents per year. However, the quality and intensity of treatment improved considerably over this period. The use of clot-busting drugs (thrombolysis) more than doubled, mechanical procedures to remove clots (thrombectomy) increased by nearly half, and more patients received surgery or stenting to clear blocked neck arteries. Patients were also more likely to leave the hospital with medications to prevent future strokes, and hospital stays became shorter. The study also found important differences in who received which treatments and what outcomes looked like. Men were more likely to receive artery-opening procedures in the neck, while rates of clot-busting and thrombectomy were similar between men and women. Women tended to be older when they had their stroke. Patients who were older or had more health problems were more likely to die within five years, while those who received clot-busting treatment or were discharged with preventive medications had better survival. The pattern of care also differed depending on the underlying cause of the stroke. This research is notable because it was conducted without a dedicated national stroke registry, instead relying on linked administrative health databases — a method that may be useful for other countries in similar situations. The authors highlight that despite overall improvements, gains were uneven across different patient groups and types of care, and they argue that establishing a formal national stroke registry would allow for more detailed and targeted quality improvement efforts going forward.

Have a question about this study?

Citation

Furlan T, Jug B, Nograšek N, Gavrić D, Oblak J, Bonča P, et al.. (2026). Acute ischemic stroke trends in Slovenia, 2015-2022: declining admissions, rising reperfusion, uneven gains.. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. https://doi.org/10.1016/j.jstrokecerebrovasdis.2026.108668